Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:2566-2570
Published online before print November 10, 2005, doi: 10.1161/01.STR.0000190833.43791.be
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/12/2566    most recent
01.STR.0000190833.43791.bev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hegele, R. A.
Right arrow Articles by Spence, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hegele, R. A.
Right arrow Articles by Spence, J. D.
Related Collections
Right arrow Clinical genetics
Right arrow Pathophysiology
Right arrow Type 2 diabetes
Right arrow Carotid Stenosis
Right arrow Doppler ultrasound, Transcranial Doppler etc.
Right arrow Pathology of Stroke
Right arrow Genetics of cardiovascular disease

(Stroke. 2005;36:2566.)
© 2005 American Heart Association, Inc.


Original Contributions

Disparate Associations of a Functional Promoter Polymorphism in PCK1 With Carotid Wall Ultrasound Traits

Robert A. Hegele, MD; Khalid Z. Al-Shali, MD; Andrew A. House, MD; Anthony J.G. Hanley, PhD; Stewart B. Harris, MD; Mary Mamakeesick, BScN; Aaron Fenster, PhD; Bernard Zinman, MD; Henian Cao, MD J. David Spence, MD

From the Robarts Research Institute (R.A.H., K.Z.A.-S., A.F., H.C., J.D.S.) London, Ontario, Canada; Department of Medicine (A.A.H.), University of Western Ontario, London, Ontario, Canada; Department of Medicine and Samuel Lunenfeld Research Institute (A.J.G.H., B.Z.), Mount Sinai Hospital and University of Toronto, Ontario, Canada; Thames Valley Family Practice Research Unit (S.B.H.), University of Western Ontario, London, Ontario, Canada; and Sandy Lake Health and Diabetes Project (M.M.), Sandy Lake, Ontario, Canada.

Correspondence to Robert A. Hegele, MD, FRCPC, FACP, Blackburn Cardiovascular Genetics Laboratory, Robarts Research Institute, 406-100 Perth Dr, London, Ontario, Canada N6A 5K8. E-mail hegele{at}robarts.ca

Background and Purpose— Cytosolic phosphoenolpyruvate carboxykinase (PEPCK; EC 4.1.1.32), encoded by PCK1, catalyzes the first committed step in gluconeogenesis. We previously showed that a –232C>G promoter polymorphism within a cis-acting element required for basal and cAMP-mediated PCK1 gene transcription results in loss of negative regulation by insulin, contributing to worsened metabolic control in the context of insulin resistance. We hypothesized that this polymorphism would be associated with carotid atherosclerosis in a sample of 150 aboriginal Canadians.

Methods— Dependent variables were 2 distinct carotid traits, namely intima-media thickness (IMT) assessed using B-mode ultrasound and total carotid plaque volume (TPV) assessed using 3D ultrasound.

Results— Multivariate analysis showed significant but opposite associations of PCK1 genotype with these traits. Specifically, subjects with the PCK1–232G/G genotype had more carotid IMT (0.80±0.02 versus 0.73±0.03 mm; P=0.007) but less TPV (0.10±0.09 versus 0.38±0.13; P=0.03) than subjects with other genotypes.

Conclusions— The findings connect the key enzyme in gluconeogenesis with atherosclerosis. The meaning of the opposing associations of PCK1 genotype with IMT and TPV is unclear; more work is required to confirm whether these might be distinct quantitative traits with different biological determinants.


Key Words: atherosclerosis • diabetes mellitus • genetics • risk factors




This article has been cited by other articles:


Home page
Circ. Res.Home page
J. E. Kanter, F. Johansson, R. C. LeBoeuf, and K. E. Bornfeldt
Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques?
Circ. Res., March 30, 2007; 100(6): 769 - 781.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Iglseder, H. Oberkofler, T. K. Felder, K. Klein, B. Paulweber, F. Krempler, D. A. Tregouet, and W. Patsch
Associations of PPARGC1A Haplotypes With Plaque Score but Not With Intima-Media Thickness of Carotid Arteries in Middle-Aged Subjects
Stroke, September 1, 2006; 37(9): 2260 - 2265.
[Abstract] [Full Text] [PDF]